Richard M. Sherry, M.D.

Team Member of:
Dr. Sherry is a senior member of the Surgery Branch immunotherapy team and also serves as a consultant surgeon at the NCI Center for Cancer Research and the NIH Clinical Center. His work is focused on the design and conduct of clinical trials that seek to translate the principles of tumor immunology elucidated in basic science laboratories. These efforts have helped to develop effective immunotherapies for patients with advanced cancer that include Interleukin-2, Ipilimumab, tumor infiltrating lymphocytes (TIL), and chimeric antigen receptor(CAR) T Cells. Dr. Sherry is also involved with the clinical training, education, and professional development of Surgery Branch fellows
1) immunotherapy, 2) T cell adoptive therapy, 3) genetically-modified peripheral blood lymphocytes, 4) melanoma, 5) clinical trial design in oncology
Contact Info
Center for Cancer Research
National Cancer Institute
Building 10, Room 2B38
Bethesda, MD 20892
Ph: 240-760-6219
Richard_Sherry@nih.gov
Dr. Sherry’s research is directed to the clinical development of effective immunotherapies for patients with common cancers based on the adoptive transfer of autologous TIL and genetically modified lymphocytes. These efforts involve the translation of novel findings and strategies in tumor immunology developed in Surgery Branch laboratories and cell processing facilities and include protocol development, patient accrual, management of patients with advanced cancer, and data analysis. His research goal is to make cellular cancer immunotherapy effective, safe, and practical.
Selected Recent Publications
- J Clin Oncol. 33(14): 1543-50, 2015. [ Journal Article ]
- Clin Cancer Res. 21(10): 2278-88, 2015. [ Journal Article ]
- Clin Cancer Res. 21(5): 1019-27, 2015. [ Journal Article ]
- J Clin Oncol. 33(6): 540-9, 2015. [ Journal Article ]
- J Immunother. 36(2): 133-51, 2013. [ Journal Article ]
Dr. Sherry is a graduate of Tufts University and the University of Pennsylvania School of Medicine. He trained in surgery at the University of Pennsylvania and the Kaiser Foundation in San Francisco and subsequently completed a fellowship in surgical oncology and immunotherapy at the NCI Surgery Branch. From 1991 to 1998, Rick held joint appointments as an attending surgeon in surgical oncology at the Georgia Regents Medical Center and the Augusta Veterans Administration Hospital where he rose to the rank of Associate Professor of Surgery. In 1998, he was recruited to the senior staff of the NCI Surgery Branch. Dr. Sherry is a diplomate of the American Board of Surgery, a Fellow of the American College of Surgeons, and an attending surgeon at the NIH Clinical Center. He is a co-recipient of the Society for Immunotherapy of Cancer Team Science Award and a NIH Clinical Center Directors Award for Strategic Initiatives.
Research
Dr. Sherry’s research is directed to the clinical development of effective immunotherapies for patients with common cancers based on the adoptive transfer of autologous TIL and genetically modified lymphocytes. These efforts involve the translation of novel findings and strategies in tumor immunology developed in Surgery Branch laboratories and cell processing facilities and include protocol development, patient accrual, management of patients with advanced cancer, and data analysis. His research goal is to make cellular cancer immunotherapy effective, safe, and practical.
Publications
Selected Recent Publications
- J Clin Oncol. 33(14): 1543-50, 2015. [ Journal Article ]
- Clin Cancer Res. 21(10): 2278-88, 2015. [ Journal Article ]
- Clin Cancer Res. 21(5): 1019-27, 2015. [ Journal Article ]
- J Clin Oncol. 33(6): 540-9, 2015. [ Journal Article ]
- J Immunother. 36(2): 133-51, 2013. [ Journal Article ]
Biography
Dr. Sherry is a graduate of Tufts University and the University of Pennsylvania School of Medicine. He trained in surgery at the University of Pennsylvania and the Kaiser Foundation in San Francisco and subsequently completed a fellowship in surgical oncology and immunotherapy at the NCI Surgery Branch. From 1991 to 1998, Rick held joint appointments as an attending surgeon in surgical oncology at the Georgia Regents Medical Center and the Augusta Veterans Administration Hospital where he rose to the rank of Associate Professor of Surgery. In 1998, he was recruited to the senior staff of the NCI Surgery Branch. Dr. Sherry is a diplomate of the American Board of Surgery, a Fellow of the American College of Surgeons, and an attending surgeon at the NIH Clinical Center. He is a co-recipient of the Society for Immunotherapy of Cancer Team Science Award and a NIH Clinical Center Directors Award for Strategic Initiatives.